Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.Financial_Report.xls
10-K - ANNUAL REPORT - Cannabics Pharmaceuticals Inc.amcm_10k31aug12.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R18.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R10.htm
EX-32.1 - CERTIFICATION - Cannabics Pharmaceuticals Inc.amcm_10k31aug12ex32.htm
EX-31.1 - CERTIFICATION - Cannabics Pharmaceuticals Inc.amcm_10k31aug12ex31.htm
v2.4.0.6
Shareholders Equity (USD $)
Common Stock
Additional Paid-In Capital
Retained Earnings / Accumulated Deficit
Total
Beginning Balance, Amount at Sep. 14, 2004        
Issuance of common stock for cash (shares) 500,000      
Issuance of common stock for cash (amount) $ 50 $ 450   $ 500
Imputed interest from shareholder   21   21
Net loss and comprehensive loss for the year     (1,800) (1,800)
Ending Balance, Amount at Aug. 31, 2005 50 471 (1,800) (1,279)
Ending Balance, Shares at Aug. 31, 2005 500,000      
Share subscriptions received   165,000   165,000
Imputed interest from shareholder   750   750
Net loss and comprehensive loss for the year     (20,021) (20,021)
Ending Balance, Amount at Aug. 31, 2006 50 166,221 (20,021) 144,450
Beginning Balance, Shares at Aug. 31, 2006 500,000      
Issuance of common stock for cash (shares) 180,198      
Issuance of common stock for cash (amount) 18 360,377   360,395
Share subscriptions received   (165,000)   (165,000)
Imputed interest from shareholder   687   687
Net loss and comprehensive loss for the year     (23,203) (23,203)
Ending Balance, Amount at Aug. 31, 2007 68 362,285 (23,203) 317,329
Ending Balance, Shares at Aug. 31, 2007 680,198      
Net loss and comprehensive loss for the year     (27,458) (27,458)
Ending Balance, Amount at Aug. 31, 2008 68 362,285 (45,024) 289,871
Ending Balance, Shares at Aug. 31, 2008 680,198      
Net loss and comprehensive loss for the year     (114,921) (114,921)
Ending Balance, Amount at Aug. 31, 2009 68 362,285 (187,403) 174,950
Beginning Balance, Shares at Aug. 31, 2009 680,198      
Issuance of common stock for cash (shares) 4      
Issuance of common stock for cash (amount) 0 0   0
Net loss and comprehensive loss for the year     (114,980) (114,980)
Ending Balance, Amount at Aug. 31, 2010 68 362,285 (302,383) 59,970
Ending Balance, Shares at Aug. 31, 2010 680,202      
Net loss and comprehensive loss for the year     (107,310) (107,310)
Ending Balance, Amount at Aug. 31, 2011 68 362,285 (409,693) (47,340)
Ending Balance, Shares at Aug. 31, 2011 680,202     680,202
Net loss and comprehensive loss for the year     (1,652) (1,652)
Ending Balance, Amount at Aug. 31, 2012 $ 68 $ 362,285 $ (411,345) $ (48,992)
Ending Balance, Shares at Aug. 31, 2012 680,202     680,202